AOSDY1 2
MAR i + 2055
VaPORMAX™ Side Firing Fiber
This summary of 510(k) safety and effectiveness information is being submitted in
accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
I. Submitter Information: Trimedyne, Inc.
15091 Bake Parkway
Irvine, CA 92618
949-951-3800
Contact Person: Glenn Yeik
President and COO
Summary Date: 4 March 2005
Il. Device Name
Proprietary: VAPORMAX™
Common: Laser Fiber
Classification: Accessory to Laser-Powered Instrument
I, Predicate Device
The predicate devices for the VAPORMAX Side Firing Fiber are:
¢ Trimedyne Side Firing Fibers cleared under 510(k)s K915223, K992230 and
K022655; and
e Lumenis DUOTOME SIDELITE™ believed to have been cleared under K011703
and/or K990947.
IV. Device Description
The VAPORMAx is a single use, disposable, side firing, fiber optic energy delivery
device for use with cleared Holmium:YAG lasers.
Vv. Intended Use
The VAPORMAx is intended for surgical use including: incision, excision,
vaporization, ablation, and coagulation of soft tissue.
The VAPORMAx is indicated for use with any cleared Holmium:YAG
2.1 micrometer laser with a compatible connector for that laser's cleared
indications for use.
Vi. Technological Characteristics
The VAPORMAX differs from the current Trimedyne side firing devices in that it
can be used at laser powers up to 100 watts, rather than 40-60 watts.
Amended SSE.doc 4-Mar-05 41

Vil. Nonclinical Data
No nonclinical data were submitted in this Premarket Notification.
Vill. Clinical Data
No clinical tests were submitted in this Premarket Notification.
IX. Conclusions Drawn From Testing
The VAPORMAX performs as intended and has acceptable mechanical properties
when used in accordance with its labeling.
Amended SSE.doc 4-Mar-05 2

wre,
: i DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
% co
we |
Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
‘Trimedyne, Inc. MAR 4 - 2005
c/o Mr. Morten S. Christensen
Underwriters Laboratories, Inc.
1655 Scott Boulevard
Santa Clara, California 95050
Re: K050412
‘Trade/Device Name: VaporMAX™
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and
plastic surgery and in dermatology
Regulatory Class: IL
Product Code: GEX
Dated: March 4, 2005
Received: March 7, 2005
Dear Mr. Christensen:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments. or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug.
and Cosmetic Act (Act) that do not require approval of a premarket approval! application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class Il (Special Controls) or class IT] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Mr. Morten S. Christensen
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results ina classification for your device and thus. permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also. please note the regulation entitled.
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Smail
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www. fda.gov/edrh/industry/support/index. hunt.

Sincerely yours, ar

ie.
/ “U
f Miriam C. Provost, Ph.D.
j Acting Director
Division of General, Restorative
and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health ;
Enclosure

indications for Use
510(k) Number (if known):
Device Name: VAPORMAX™
Indications for Use:
The VAPORMAX is intended for surgical use including: incision, excision, vaporization, ,
ablation, and coagulation of soft tissue.
The VAPORMAX is indicated for use with any cleared Holmium:YAG 2.1 micrometer
laser with a compatible connector for that laser's cleared indications for use.
Prescription Use X Over-The-Counter Use
(Part 21 CFR 801 Subpart D) AND/OR (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE
IF NEEDED)
Concurrence of CDRH, Office of ce Evaluation (ODE)
Tea a
(Division Sign-Off}
Division of General, Restorative,
rological Devices
and New ologi ; Page 1 of _1
Kgs 0H le
510(k) Number_——_£-_--_—

